239 related articles for article (PubMed ID: 32109993)
1. Colon Targeting of Naringin for Enhanced Cytoprotection Against Indomethacin-Induced Colitis in Rabbits.
El Naggar EE; Mohamed EA; Borg TM; El-Sheakh AR; Hamed MF
Drug Des Devel Ther; 2020; 14():677-696. PubMed ID: 32109993
[TBL] [Abstract][Full Text] [Related]
2. Optimization of budesonide compression-coated tablets for colonic delivery.
Yehia SA; Elshafeey AH; Sayed I; Shehata AH
AAPS PharmSciTech; 2009; 10(1):147-57. PubMed ID: 19199041
[TBL] [Abstract][Full Text] [Related]
3. Site Targeted Press Coated Delivery of Methylprednisolone Using Eudragit RS 100 and Chitosan for Treatment of Colitis.
Jagdale S; Chandekar A
Recent Pat Antiinfect Drug Discov; 2016; 11(1):32-43. PubMed ID: 26377799
[TBL] [Abstract][Full Text] [Related]
4. Bumadizone calcium dihydrate microspheres compressed tablets for colon targeting: formulation, optimization and in vivo evaluation in rabbits.
Nour SA; Abdelmalak NS; Naguib MJ
Drug Deliv; 2015 May; 22(3):286-97. PubMed ID: 24601826
[TBL] [Abstract][Full Text] [Related]
5. Gastroretentive Matrix Tablets of Boswellia Oleogum Resin: Preparation, Optimization, In Vitro Evaluation, and Cytoprotective Effect on Indomethacin-Induced Gastric Ulcer in Rabbits.
Yusif RM; Abu Hashim II; Mohamed EA; Badria FA
AAPS PharmSciTech; 2016 Apr; 17(2):328-38. PubMed ID: 26092303
[TBL] [Abstract][Full Text] [Related]
6. Preparation and in vitro/in vivo evaluation of dextran matrix tablets of budesonide in experimental ulcerative colitis in rats.
Ahmadi F; Varshosaz J; Emami J; Tavakoli N; Minaiyan M; Mahzouni P; Dorkoosh F
Drug Deliv; 2011 Feb; 18(2):122-30. PubMed ID: 20954795
[TBL] [Abstract][Full Text] [Related]
7. Self-nanoemulsifying drug-delivery systems for potentiated anti-inflammatory activity of diacerein.
Eltobshi AA; Mohamed EA; Abdelghani GM; Nouh AT
Int J Nanomedicine; 2018; 13():6585-6602. PubMed ID: 30425476
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of resveratrol encapsulated microsponges delivered by pectin based matrix tablets in rats with acetic acid-induced ulcerative colitis.
Gandhi H; Rathore C; Dua K; Vihal S; Tambuwala MM; Negi P
Drug Dev Ind Pharm; 2020 Mar; 46(3):365-375. PubMed ID: 32041433
[No Abstract] [Full Text] [Related]
9. Design and evaluation of pH modulated controlled release matrix systems for colon specific delivery of indomethacin.
Asghar LF; Chandran S
Pharmazie; 2008 Oct; 63(10):736-42. PubMed ID: 18972836
[TBL] [Abstract][Full Text] [Related]
10. Formulation and characterizations of delayed release multi particulates system of indomethacin: optimization by response surface methodology.
Nandy BC; Mazumder B
Curr Drug Deliv; 2014; 11(1):72-86. PubMed ID: 24783236
[TBL] [Abstract][Full Text] [Related]
11. Formulation and optimization of theophylline-loaded enteric-coated spanlastic nanovesicles for colon delivery; Ameliorate acetic acid-induced ulcerative colitis.
Barakat EH; Akl MA; Ibrahim MF; Mohamed Dawaba H; Afouna MI
Int J Pharm; 2023 Aug; 643():123253. PubMed ID: 37473974
[TBL] [Abstract][Full Text] [Related]
12. Controlled delivery of a new broad spectrum antibacterial agent against colitis: In vitro and in vivo performance.
Nieto-Bobadilla MS; Siepmann F; Djouina M; Dubuquoy L; Tesse N; Willart JF; Dubreuil L; Siepmann J; Neut C
Eur J Pharm Biopharm; 2015 Oct; 96():152-61. PubMed ID: 26209123
[TBL] [Abstract][Full Text] [Related]
13. Formulation and evaluation of different floating tablets containing metronidazole to target stomach.
Loh ZC; Elkordy AA
Curr Drug Deliv; 2015; 12(4):425-43. PubMed ID: 25924732
[TBL] [Abstract][Full Text] [Related]
14. Design of experiment approach for formulating multi-unit colon-targeted drug delivery system: in vitro and in vivo studies.
Shah N; Sharma OP; Mehta T; Amin A
Drug Dev Ind Pharm; 2016; 42(5):825-35. PubMed ID: 27019195
[TBL] [Abstract][Full Text] [Related]
15. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 combinations.
Khan MZ; Prebeg Z; Kurjaković N
J Control Release; 1999 Mar; 58(2):215-22. PubMed ID: 10053194
[TBL] [Abstract][Full Text] [Related]
16. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
[TBL] [Abstract][Full Text] [Related]
17. Achillea wilhelmsii-Incorporated Chitosan@Eudragit Nanoparticles Intended for Enhanced Ulcerative Colitis Treatment.
Maleki H; Doostan M; Farzaei MH; Seifi P; Miraghaee S; Doostan M
AAPS PharmSciTech; 2023 Apr; 24(5):112. PubMed ID: 37118443
[TBL] [Abstract][Full Text] [Related]
18. Naringin Exhibited Therapeutic Effects against DSS-Induced Mice Ulcerative Colitis in Intestinal Barrier-Dependent Manner.
Cao R; Wu X; Guo H; Pan X; Huang R; Wang G; Liu J
Molecules; 2021 Oct; 26(21):. PubMed ID: 34771012
[TBL] [Abstract][Full Text] [Related]
19. Polymeric micelles for potentiated antiulcer and anticancer activities of naringin.
Mohamed EA; Abu Hashim II; Yusif RM; Shaaban AAA; El-Sheakh AR; Hamed MF; Badria FAE
Int J Nanomedicine; 2018; 13():1009-1027. PubMed ID: 29497294
[TBL] [Abstract][Full Text] [Related]
20. A pH-dependent colon-targeted oral drug delivery system using methacrylic acid copolymers. II. Manipulation of drug release using Eudragit L100 and Eudragit S100 combinations.
Khan MZ; Stedul HP; Kurjaković N
Drug Dev Ind Pharm; 2000 May; 26(5):549-54. PubMed ID: 10789067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
